Pipeline of Development-Stage RAS(ON) Inhibitors to be Highlighted in Four Presentations in “Targeting the RAS Oncogene” Session, as well as…
MALVERN, Pa., March 09, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,…
OCALA, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma…
New structure replaces existing facility with a significant interest rate reduction resulting in approximately $2.8 million of annualized interest savingsWATERTOWN,…
myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all…
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M Issuing FY 2022 revenue guidance of $260M - $270M, representing…
The company reiterates full year 2022 guidanceSEATTLE, March 09, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage…
NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…
Toronto, Ontario--(Newsfile Corp. - March 9, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a…
World-Renowned Healthcare Provider and Insurer Deepens Relationship through Direct Investment and Collaboration with Leading Digital Health Company BOSTON--(BUSINESS WIRE)--Kyruus, the…